At the Intersection of Science and Law

At the Intersection of Science and Law

by

In DLA Piper’s At the Intersection of Science and Law podcast, members of the firm’s Life Sciences team explore the connection between science and the law in areas that include AI and drug discovery, mRNA technology, and the regulatory implications of new drugs and devices.

Recent Episodes

  • Revolutionizing Clinical Trials: A discussion on diversity and patient-centric approaches

    8 months ago
  • Life sciences companies and the risks posed by the mifepristone litigation

    2 years ago
  • Trade secrets protection in the life sciences sector

    2 years ago
  • Cross-border considerations for privacy in clinical trials

    2 years ago
  • Global Life Sciences Supply Chain Insights

    3 years ago
  • AI risk assessments: Future-proofing your innovation when rules can change mid-game

    3 years ago
  • The rise of global telehealth

    3 years ago
  • Advising the advisor: Tips for navigating the life sciences and regulatory environment

    3 years ago
  • The moral imperative: Balancing innovation, regulation and prescription drug availability

    3 years ago
  • Incentivizing diverse representation in clinical trials

    3 years ago